FARALLON CAPITAL MANAGEMENT LLC

Q3 2023 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
9/30/2023
Date filed
11/14/2023
Form type
13F-HR
Num holdings
159
Total value ($000)
$19,950,818
Net value change ($000)
+2,055,741 (11.5%)
New positions
31
Sold out positions
29
Turnover %
31.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/14/2023 Next filing: 2/14/2024 SEC filing

Snapshot: Change Analysis

Compared to Q2 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AIY 1,902,562 NEW
Horizon Therapeutics Public Ltd Co 770,128 NEW
CHTR 488,790 NEW
CBRE 333,876 NEW
MSFT 132,737 45.3%
CRM 101,388 24.7%
UNH 73,963 12.2%
EXEL 70,856 14.3%
VRTX 70,243 NEW
HUM 61,752 53.4%
Top Reduces (Value $000, Stocks/ETFs)
IQV -324,935 -37.4%
EFX -249,111 -100.0%
BIIB -172,077 -100.0%
XYZ -119,206 -53.5%
TMO -118,650 -18.3%
SHW -98,210 -26.9%
IVERIC bio, Inc. -96,080 -100.0%
BABA -81,075 -52.0%
V -71,683 -29.0%
HWM -70,726 -24.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 3,719,076 (18.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type